Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-065303
Filing Date
2009-11-24
Accepted
2009-11-23 19:22:57
Documents
10
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c92967e10vq.htm 10-Q 887907
2 EXHIBIT 4.1 c92967exv4w1.htm EX-4.1 1138
3 EXHIBIT 4.2 c92967exv4w2.htm EX-4.2 80549
4 EXHIBIT 10.1 c92967exv10w1.htm EX-10.1 80293
5 EXHIBIT 10.2 c92967exv10w2.htm EX-10.2 25247
6 EXHIBIT 10.3 c92967exv10w3.htm EX-10.3 133333
7 EXHIBIT 31.1 c92967exv31w1.htm EX-31.1 6307
8 EXHIBIT 32.1 c92967exv32w1.htm EX-32.1 3509
9 GRAPHIC c92967p9296720.jpg GRAPHIC 104642
10 GRAPHIC c92967p9296721.jpg GRAPHIC 63544
  Complete submission text file 0000950123-09-065303.txt   1452011
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31564 | Film No.: 091202971
SIC: 2834 Pharmaceutical Preparations